Koyfin Home > Directory > Health Care > Hologic Inc

Hologic Inc Price Chart HOLX

Historical daily share price chart and data for Hologic Inc since 1990 adjusted for splits and dividends. The latest closing price for Hologic Inc as of September 13, 2019 is $49.72.
  • In 2019 the stock opened at $38.67 and closed at $49.72 for a gain of 22% YTD.
  • In 2018 the stock opened at $42.75 and closed at $41.10 for a loss of -4%.
  • In 2017 the stock opened at $40.00 and closed at $42.75 for a gain of 6%.
  • In 2016 the stock opened at $38.38 and closed at $40.12 for a gain of 4%.
View Chart On Koyfin

Hologic Inc Summary

Stock Symbol: HOLX

Hologic Inc Company Info

Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. The company offers Aptima molecular diagnostic assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and analytics products, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, and breast biopsy and biopsy site markers, as well as localization, specimen radiology, ultrasound, and connectivity solutions. In addition, the company offers Selenia Dimensions and 3Dimensions gantries for performing 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D software products; SecurView Workstations; computer aided detection systems; and stereotactic breast biopsy systems. Further, it provides SculpSure, PicoSure, and MonaLisa Touch aesthetic treatment systems; TempSure, a radio frequency energy sourced platform; and MedLite and other products, and system components for medical aesthetics. Additionally, the company offers NovaSure, an endometrial ablation system to treat women suffering from abnormal uterine bleeding; MyoSure surgical products for removal of fibroids, and uterine polyps and other pathology; and Horizon DXA System and Fluoroscan Insight FD skeletal health products. It sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
457 %
30D Volatility
Hedge Fund Held
6.07 %

Last 10 Days of HOLX Prices